货号:A528135
同义名:
ATM Kinase Inhibitor
KU-55933是一种高效的 ATM 抑制剂,其 IC50 和 Ki 值分别为 12.9 nM 和 2.2 nM,与 DNA-PK、PI3K/PI4K、ATR 和 mTOR 相比,对 ATM 的选择性极高。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | ATM ↓ ↑ | ATR ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wortmannin |
++
ATM, IC50: 150 nM |
DNA-PK,PI3K,MLCK | 99%+ | ||||||||||||||||
| CP-466722 |
+
ATM, IC50: 410 nM |
99%+ | |||||||||||||||||
| Torin 2 |
++
ATM, EC50: 28 nM |
++
ATR, EC50: 35 nM |
DNA-PK,mTOR | 99%+ | |||||||||||||||
| KU-55933 |
+++
ATM, IC50: 12.9 nM |
96% | |||||||||||||||||
| ETP-46464 |
+
ATM, IC50: 545 nM |
+++
ATR, IC50: 14 nM |
DNA-PK,mTOR | 98% | |||||||||||||||
| CGK733 |
++
ATM, IC50: 200 nM |
++
ATR, IC50: 200 nM |
99%+ | ||||||||||||||||
| AZD0156 | ✔ | 99%+ | |||||||||||||||||
| Dactolisib |
+++
ATR, IC50: 21 nM |
98+% | |||||||||||||||||
| Ceralasertib |
++++
ATR, IC50: 1 nM |
99%+ | |||||||||||||||||
| Berzosertib |
+++
ATR, IC50: 19 nM |
99%+ | |||||||||||||||||
| VE-821 |
+++
ATR, Ki: 13 nM |
99%+ | |||||||||||||||||
| AZ20 |
++++
ATR, IC50: 5 nM |
mTOR | 99%+ | ||||||||||||||||
| Schizandrin B |
+
ATR, IC50: 7.25 μM |
P-gp | 98% | ||||||||||||||||
| m-PEG25-NHS ester |
++++
ATR, IC50: 7 nM |
95% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | The serine/threonine protein kinase ATM signals can regulate cell cycle and DNA repair components through phosphorylation on the targets such as p53, CHK2, NBS1, and BRCA1, thus playing a central role in the maintenance of genome integrity. KU-55933 is a specific ATM inhibitor with IC50 value of 13nM and Ki value of 2.2nM (measured by ATM kinase activity). After exposure to 5 Gy of irradiation, treatment with 10μM KU-55933 caused increased phosphorylation of p53 at serine 15 site, a marker of ATM activity, in a time-dependent manner in U2OS cells in within 4 hours. A range of ATM target phosphorylation events, including pH2AX-ser139, pNBS1-ser343, pCHK1-ser345, or pSMC1-ser966, were decreased by pretreatment with 10μM KU-55933 for 1h before irradiation 3Gy or 15Gy in U2OS cells. The radiosensitization by KU-55933 can be observed in HeLa cells pre-treated with 10μM KU-55933 before a range of ionizing radiation (0-4Gy). Also it can sensitize HeLa cells to the cytotoxic effects of the topoisomerase II inhibitors etoposide, doxorubicin, amsacrine and the topoisomerase I inhibitor camptothecin. These suggested that KU-55933 performed as a radio- and chemosensitizer[1]. |
| 作用机制 | KU-55933 is an ATP-competitive ATM inhibitor.[1] |
| Concentration | Treated Time | Description | References | |
| HepG2 cells | 10 mM | 2 h | Inhibition of ATM activity enhanced aescin-induced apoptosis | Acta Pharmacol Sin. 2018 Dec;39(12):1874-1884. |
| AD-293 cells | 8.3 μM | 24 h | KU-55933 suppressed Id-1 expression through high-throughput screening | Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2318718121. |
| human vascular endothelial cells | 10 μM | 24 h | inhibited Smad1/5 activation induced by disturbed flow and BMP4, and suppressed endothelial cell proliferation and inflammation | Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2318718121. |
| Human podocytes | 10 μM | 2 h | Inhibit ATM kinase activity, reduce MAD2B upregulation, and alleviate ADR-induced podocyte injury and cell cycle re-entry | Int J Biol Sci. 2021 Oct 22;17(15):4396-4408. |
| DU145 cells | 10μM | 4 h | KU55933 enhanced the radiosensitivity of DU145 cells, comparable to the effects of 30nM AZ12253801 at 10Gy, and similar to 60nM AZ12253801 at 1-10Gy. | Oncogene. 2014 Nov 6;33(45):5262-73. |
| AGS human gastric epithelial cells | 5 and 10 μM | 6 h | KU-55933 inhibited H. pylori-induced cell death and suppressed the increment of Bax/Bcl-2 ratio, caspase-3 activation, and nucleosome-bound DNA level. | J Ginseng Res. 2020 Jan;44(1):79-85. |
| B65 Neuroblastoma Cells | 10 µM | 30 min | KU-55933 significantly inhibited MPP?-induced pRb phosphorylation. | Cell Mol Life Sci. 2010 Nov;67(22):3865-82. |
| Cerebellar Granule Cells (CGC) | 1-10 µM | 24 h | KU-55933 showed neuroprotective effects against MPP?-induced neuronal apoptosis, reducing nuclear condensation and DNA fragmentation. | Cell Mol Life Sci. 2010 Nov;67(22):3865-82. |
| Human corneal epithelial cells (hTCEpi) | 10 µM | 24 h | Inhibition of ATM activity significantly reduced HSV-1 viral replication and cytopathic effect | Invest Ophthalmol Vis Sci. 2014 Feb 3;55(2):706-15. |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | A549 cell xenograft model | Intraperitoneal injection | 10 mg/kg | Administered 1 day before radiotherapy and every other day thereafter | To verify the regulatory role of ATM on tumor growth under low-dose radiation. Results showed that the ATM inhibitor alone inhibited the growth of A549 tumors, and the effect was more pronounced when combined with low-dose radiotherapy. | Front Cell Dev Biol. 2021 May 12;9:650819 |
| Apolipoprotein E-deficient mice | High-fat diet-induced atherosclerosis model | Tail vein injection | 8 mg/kg | Twice a week for 12 weeks | KU-55933 inhibited atherosclerotic lesion formation and reduced endothelial cell proliferation and inflammation | Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2318718121. |
| Mice | ADR-induced FSGS model | Intraperitoneal injection | 500 µg/kg | Every 3 days until sacrifice | Inhibit ATM kinase activity, reduce MAD2B upregulation, and alleviate ADR-induced podocyte injury and proteinuria | Int J Biol Sci. 2021 Oct 22;17(15):4396-4408. |
| C57BL/6J Mice | HSV-1 keratitis model | Topical eye drops | 200 µM | Every 4 hours for 1 day, then every 8 hours for the remainder of the experiment | KU-55933 significantly reduced the severity of stromal keratitis in mice | Invest Ophthalmol Vis Sci. 2014 Feb 3;55(2):706-15. |
| Dose | Mice: 5 mg/kg[2] (i.p.), 0.5 mg/kg[3] (i.p.), 10 mg/kg[4] (i.p.) |
| Administration | i.p. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.53mL 0.51mL 0.25mL |
12.64mL 2.53mL 1.26mL |
25.29mL 5.06mL 2.53mL |
|
| CAS号 | 587871-26-9 |
| 分子式 | C21H17NO3S2 |
| 分子量 | 395.49 |
| SMILES Code | O=C1C=C(N2CCOCC2)OC(C3=C4SC5=C(C=CC=C5)SC4=CC=C3)=C1 |
| MDL No. | MFCD08276985 |
| 别名 | ATM Kinase Inhibitor |
| 运输 | 蓝冰 |
| InChI Key | XRKYMMUGXMWDAO-UHFFFAOYSA-N |
| Pubchem ID | 5278396 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 50 mg/mL(126.42 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1